NCT07159282View on ClinicalTrials.gov

A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 26, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Diabetic FootFoot UlcerUlcer FootDFUFoot Ulcer Due to Type 2 Diabetes MellitusFoot Ulcer Due to Type 1 Diabetes MellitusDiabetic Foot Ulcer
Interventions
OTHER

XWRAP

Application of XWRAP + standard of care for up to 12 weeks.

Trial Locations (1)

33024

RECRUITING

Royal Research, Hollywood

Sponsors
All Listed Sponsors
collaborator

SerenaGroup, Inc.

NETWORK

lead

Applied Biologics, LLC

INDUSTRY

NCT07159282 - A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter